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Background: Constraint-based modeling uses mass balances, flux capacity, and reaction directionality constraints
to predict fluxes through metabolism. Although transcriptional regulation and thermodynamic constraints have
been integrated into constraint-based modeling, kinetic rate laws have not been extensively used.
Results: In this study, an in vivo kinetic parameter estimation problem was formulated and solved using multi-omic
data sets for Escherichia coli. To narrow the confidence intervals for kinetic parameters, a series of kinetic model
simplifications were made, resulting in fewer kinetic parameters than the full kinetic model. These new parameter
values are able to account for flux and concentration data from 20 different experimental conditions used in our
training dataset. Concentration estimates from the simplified kinetic model were within one standard deviation for
92.7% of the 790 experimental measurements in the training set. Gibbs free energy changes of reaction were
calculated to identify reactions that were often operating close to or far from equilibrium. In addition, enzymes
whose activities were positively or negatively influenced by metabolite concentrations were also identified. The
kinetic model was then used to calculate the maximum and minimum possible flux values for individual reactions
from independent metabolite and enzyme concentration data that were not used to estimate parameter values.
Incorporating these kinetically-derived flux limits into the constraint-based metabolic model improved predictions
for uptake and secretion rates and intracellular fluxes in constraint-based models of central metabolism.
Conclusions: This study has produced a method for in vivo kinetic parameter estimation and identified strategies
and outcomes of kinetic model simplification. We also have illustrated how kinetic constraints can be used to
improve constraint-based model predictions for intracellular fluxes and biomass yield and identify potential
metabolic limitations through the integrated analysis of multi-omics datasets.
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Constraint-based models consider the physico-chemical
constraints that exist on metabolism, including mass bal-
ances, flux capacities, thermodynamics, and transcriptional
regulation of metabolic enzymes [1,2]. One common
constraint-based modeling approach, flux balance analysis
(FBA) uses mass balance and reaction reversibility con-
straints to predict metabolic fluxes that maximize flux
through a reaction or combination of reactions [2]. FBA* Correspondence: reed@engr.wisc.edu
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distribution, and reproduction in any mediumtypically is used to find flux distributions that maximize
biomass production or ATP generation per total flux [3].
Some constraint-based models add transcriptional regula-
tory constraints to further limit flux values [4-6] when the
associated enzymes are known to be unexpressed in certain
conditions. Thermodynamic constraints have also been
imposed to limit the direction a given reaction can
proceed, and thermodynamic metabolic flux analysis
(TMFA) uses these constraints to ensure that reactions
only proceed in the thermodynamically-favorable direction
[7-10]. TMFA models were some of the first constraint-
based models that directly accounted for intracellular me-
tabolite concentrations.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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models have largely been divergent methodologies in sys-
tems biology. In constraint-based modeling, omission of
kinetic considerations is generally seen as an advantage of
the methodology, since determining kinetic information for
an entire metabolic network is currently infeasible. How-
ever, FBA and TMFA predictions are not always consistent
with experimental observations because of kinetic limita-
tions on native enzymes. To account for these kinetic lim-
itations, there have been some efforts to integrate kinetic
expressions into constraint-based models. Beg et al. [11]
were able to improve predictions of cellular growth rates by
constraining fluxes using individual enzyme activity, en-
zyme volume needed to achieve a given flux, and the total
enzyme volume. More recently, Yizhak et al. [12] integrated
metabolomic and proteomic data into Michaelis-Menten
kinetic expressions using in vitro Km parameters to more
accurately predict flux changes (increases/decreases) than
methods that did not consider kinetics. Similarly, dynamic
flux balance analysis models have also used Michaelis-
Menten kinetic expressions to constrain substrate uptake
rates based on reactor concentrations [13-15].
In the present study, we estimated kinetic parameters in
a kinetic model of central Escherichia coli metabolism by
integrating fluxomic, proteomic, and metabolomics data.
Data published by Ishii et al. [16] from single deletion
mutants and the parental strain (at different growth rates)
were used to construct a weighted sum of least squares
(WSLS) parameter estimation problem using kinetic rate
laws. Initially rate laws reported by Chassagnole et al. [17]
were used; however, these rate laws resulted in parameters
with large confidence intervals. A simplified kinetic model
was subsequently constructed that resulted in smaller con-
fidence intervals for kinetic parameters. Predictions from
the kinetic model for metabolite concentrations and kin-
etic parameters were used to draw conclusions about
metabolite-mediated inhibition and activation effects on
enzymes, and distance from equilibrium for reactions in
central metabolism. Using independent data sets, we then
used the kinetic model to predict flux ranges that are con-
sistent with estimated kinetic parameters and concentra-
tion data. We subsequently incorporated these flux ranges
as constraints into a constraint-based model to improve
predictions over FBA. This new constraint-based model
with kinetic constraints is one of the most detailed
constraint-based models with kinetic constraints to date,




A central E. coli constraint-based metabolic model previ-
ously reported by Palsson [18] was used that included
glycolysis, pentose phosphate, oxidative phosphorylation,and the citric acid pathways. This model was chosen be-
cause it includes the fluxes, proteins, and metabolites
measured by Ishii et al. [16]. This model included mass
balance constraints for central metabolic intermediates, as
well as energy and redox carriers. Fluxes from Ishii et al.
[16] were adjusted slightly to satisfy mass balance con-
straints and energy requirements in the metabolic models
by minimizing the Euclidean distance between the fluxes
in the constraint-based model and the reported flux distri-
butions. These adjusted flux measurements were then
used to estimate kinetic parameters and evaluate model-
predicted fluxes from a constraint-based model with kin-
etic constraints. The most recent genome-scale model of
E. coli (iJO1366) [19] was also used to evaluate the effects
of kinetic constraints. A few reactions were excluded from
the model (EDD, HEX1, F6PA, FBA3, FLDR2, and DRPA)
so that the adjusted fluxes more closely matched the mea-
sured flux patterns.Kinetic parameter estimation using multi-omic data
In general, kinetic rate laws can be written in the form
v=e f(c;θ), where the flux (v) is proportional to the con-
centration of the associated enzyme (e) and some mech-
anistic function (f ) of metabolite concentrations (c) and
kinetic parameters (θ). To estimate kinetic parameters,
data on fluxes, metabolite, and enzyme concentrations
generated by Ishii et al. [16] was used. Rate laws based
on those reported by Chassagnole et al. [17] were used
(Additional file 1: Table S1). The adenylate energy charge
(Equation 1c) was also constrained to be at least 0.8, based
on typical experimental values [20]. This constraint was
used since ATP concentrations were not measured, but
were used in many kinetic rate laws. The adenylate energy
charge then relates ATP concentration to measured AMP
and ADP concentrations. Parameters in the kinetic model
were then estimated using nonlinear regression. The
adjusted flux measurements for each experimental condi-
tion were used in a kinetic model, where a weighted sum
of least squares (WSLS) kinetic parameter estimation
problem was formulated (Equations 1a-1e). In this case,
fluxes and kinetic constraints were used to find kinetic
parameters that were most consistent with measured me-
tabolite and protein concentrations. The full WSLS par-
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Here, I is the set of metabolites, K is the set of reac-
tions with kinetic rate laws, L is the set of experimental
conditions, and θ is a vector of all kinetic parameter
values. Parameters except for equilibrium constants were
assigned global upper and lower bounds of 104 and 10-6,
respectively (in their respective units). The estimates of
metabolite and enzyme concentrations (cil and ekl) are
variables and are adjusted to be as close as possible to the
experimentally-measured metabolite and enzyme concen-
trations (cil
exp and ekl
exp). Fluxes with kinetic rate laws (vkl)
were fixed to the adjusted values from the constraint-
based model. Biologically-relevant global upper and lower
bounds were enforced on metabolite concentrations
(0.001 mM and 10 mM) and enzyme concentrations
(0.001 mg protein/gDCW and 10 mg protein/gDCW).
Kinetic parameters were allowed to vary freely, except for
equilibrium constants that were required to be within 35%
to 285% of their in vitro measured values in standard con-
ditions [21], corresponding to changes of 2.6 kJ/mol in the
Gibbs free energy change of reaction. The weights in the
WSLS objective function, Wil
c and Wkl
e , were assigned as
the inverse of experimental variances for the metabolic
and enzyme concentration measurements, respectively.
This weighting method was chosen to keep residuals on
the same scale and assign less importance to concentra-
tions with measurements that were more uncertain.
Experimental sample variances were calculated from con-
centration measurements from 4 biological replicates of
the parental strain growing steadily at 0.2 h-1.
The WSLS parameter estimation problem was solved
using CONOPT3 as called by GAMS 23.3 (GAMS De-
velopment Corporation, Washington, DC) from mul-
tiple starting points to explore the non-convex feasible
space and find multiple local optimal solutions. The
feasible solution with the lowest objective value was
selected as the set of optimal kinetic parameters values
and concentrations. Confidence intervals for the set of
kinetic parameters were estimated by determining the
sensitivity of enzyme and metabolite concentrations to
parameter values. This sensitivity was determined by
making small perturbations to parameter values one at
a time and re-optimizing Equations 1a-1e. These sensi-
tivities were used to determine confidence intervals in
a method described by Antoniewicz et al. [22]. Gener-
ally, smaller WSLS values and higher sensitivities lead
to smaller confidence intervals and more confidence inparameters. Five conditions (Δpgm, ΔgpmA, Δzwf,
ΔtktB, and parental strain at D=0.5 h-1) were randomly
drawn from the set of experimental conditions and left
out during parameter estimation, to form an independ-
ent test set to later evaluate the resulting constraint-
based model.
Predictions using FBA with kinetic constraints (KFBA)
A method to improve FBA using kinetic constraints was
developed. This method combines a constraint-based
model with flux ranges determined by a kinetic model.
Upper and lower kinetic flux bounds for intracellular
fluxes were estimated using the kinetic model for each
test condition using the rate laws, kinetic parameter
confidence intervals, and measured metabolite and en-
zyme concentrations. Minimum (vk
min) and maximum
(vk
max) possible values for each flux were determined by
fixing the concentration measurements and allowing
kinetic parameters to vary within their 95% confidence
intervals. Metabolite and enzyme concentration measure-
ments were from experimental conditions that were not
used during kinetic model parameter estimation. Because
a steady-state metabolic flux distribution could not be
found in the constraint-based model that was consistent
with all the flux bounds calculated by the kinetic model, a
solution was found with the minimum number of kinetic
bounds violated (n*). For the five test sets evaluated using
the central metabolic model, a median of 16 out of 22 kin-
etic bounds could be enforced. The maximum number of
kinetic bounds that could be violated was set to n* for
each condition in our kinetic FBA problem
(KFBA): minv; yþ; y vPTS (2a)
such that




yk þ vmink ≤ vk ≤ UBk  vmaxk
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yþk
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Here, J is the set of all reactions, K is the subset of
reactions with kinetic rate laws, and the binary variables
y+ and y- indicate whether an upper or lower kinetic
bound is violated. A general lower bound (LB=0 or
−1000 mmol/gDW/h for irreversible and reversible reac-
tions, respectively) and an upper bound (UB=1000
mmol/gDW/h) were used for all reactions, including
those with kinetic rate laws. All fermentative pathways
were blocked (i.e., LB and UB set to 0), as only carbon
Cotten and Reed BMC Bioinformatics 2013, 14:32 Page 4 of 13
http://www.biomedcentral.com/1471-2105/14/32dioxide was produced in experiments. The choice for
UB and LB did not affect predictions, as fluxes did not
go to these limits at the optimal solutions and the kin-
etic bounds were between the LB and UB values. The
cellular growth rates (vbiomass) were fixed to the chemostat
dilution rate. An analogous FBA problem was formulated
using Equations 1a-2c. Since the FBA and KFBA solutions
are not necessarily unique, we selected the alternate opti-
mal solution with the lowest sum of squared flux values
[23] by solving an additional minimization problem, which
gives a unique answer. Residuals were calculated for the
subset of measured fluxes as the squared difference be-
tween the adjusted flux measurement and FBA or KFBA
flux prediction. When calculating the mean residual, only
one flux residual was used for fluxes that must be directly
proportional to one another based on the network stoichi-
ometry (e.g., reactions in a linear pathway).
Results
In this study, we developed a kinetic and thermodynamic
approach to integrate multi-omics datasets to constrain
metabolic fluxes (Figure 1). A kinetic model with rate laws
for a subset of enzymes in glycolysis and pentose phos-
phate pathway was developed [17]. Using fluxomic, prote-
omic, and metabolomic data, in vivo kinetic parameters

























Figure 1 Methods summary. Kinetic rate laws were fit to fluxomic,
proteomic, and metabolomics data using nonlinear least squares
regression. Of the 25 experimental conditions that were available,
20 were used for fitting, and 5 were used as a test set.
Concentration estimates from parameter fitting were used to
examine the thermodynamic and kinetic limitations of the central
metabolism. The fit kinetic parameters were used to add kinetic
constraints to a constraint-based model to estimate internal fluxes
and biomass yields. These estimates were compared to
experimental data.and protein concentration measurements. A simplified
kinetic model with an equivalent fit to the experimental
data, but with fewer kinetic parameters, was subsequently
generated. The best estimates for metabolite concentrations
and kinetic parameter values from the parameter estima-
tion problem in the simplified kinetic model were used to
draw conclusions about kinetic and thermodynamic control
in central metabolism. The simplified kinetic model was
also used to generate tighter flux bounds for constraint-
based models, allowing us to evaluate predictions for
experimental conditions that were not used in train the kin-
etic model.In vivo kinetic parameter estimation
A subset of previously reported flux, metabolite, and
protein concentration data for different E. coli strains
(knockout mutants and their parental strain, BW25113)
[16] were used to estimate values and confidence inter-
vals for kinetic parameters used in kinetic rate laws.
Non-linear optimization was used to find the optimal set
of kinetic parameter values which result in a kinetic
model with fluxes and concentrations that are closest to
experimental measurements taken from 20 different
conditions (different strains and growth rates). For most
parameters in the full kinetic model, the relative confi-
dence intervals (ratio of confidence interval length to
the optimal parameter value) were large, with more than
80% having a confidence interval that was greater than
100 times the best estimated value (Figure 2A), indicat-
ing that we could not be certain of the exact parameter
values used in the kinetic rate laws. Similar confidence
interval ratios for parameters in these same rate laws






























Figure 2 Histogram of Relative Confidence Intervals. Relative
confidence intervals in the full (A) and simplified model (B). The
relative confidence interval, the ratio of confidence interval length to
the optimal parameter value, is a measure of the resolution of
individual parameters, with smaller values indicating better
resolution. The full model had 84 parameters, while the simplified
model had 36 parameters.
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(see also Additional file 2: Table S2).
To improve confidence in estimated parameter values,
we simplified the kinetic rate laws (Table 1). Optimal par-
ameter values from the full kinetic model were examined,
and in many cases, the optimal parameter values resulted
in rate laws that were insensitive to changes in metabolite
concentrations and/or small changes in parameter values,
especially binding coefficients (Km). Though confidence
intervals for these parameters were large, it was apparent
that some of the parameter values were much smaller or
larger than the corresponding metabolite concentrations
(parameter values of 10-6 or 104 mM versus metabolite
concentrations of 10-3 to 101 mM). For simple Michaelis-
Menten rate laws the binding coefficients could be
removed if their values were close to 10-6 since they were
neglible compared to metabolite concentrations (>10-3).
Similarly, if the binding coefficients were large (104) com-
pared to the metabolite concentrations (<101) then binding
coefficient can be kept and the metabolite concentration
ommitted. For these cases, we simplified the functional
form of the rate law (Additional file 1: Table S1). As an ex-
ample, in the full rate law for phosphoglucomutase (PGM),
v ¼ kcatePGM c3pgc2pg=KeqK3pgþc3pg
 
, the optimal value of K3pg was





¼ kcatePGM 1 c2pgc3pgKeq
 
since K3pg +
c3pg ≈ c3pg. For more complicated rate laws, we examined
how the flux would change for high (101) and low (10-3)
metabolite concentrations given the optimal parameter
values to identify metabolite concentrations or parameters





vTPI kcateTPI 1 cgapcdhapKeq
 
vPGK kcatePGK 1 catpc3pgcadpc13dpgKeq
 







vRPE kcateRPE cru5pD  cxu5pDKeq
 
vTKT1 kcateTKT1 cr5pcxu5pD  cs7pcgapKeq
 
vTKT2 kcateTKT2 cxu5pDce4p  cf6pcgapKeq
 large and small parameter values lead to poor scaling in
the kinetic model during parameter fitting, and the simpler
rate laws they suggest would be more efficient to use in-
stead. The parameters that were removed also had large
confidence intervals as a result of the kinetic model's in-
sensitivity to those parameters.
The resulting simplified kinetic model had 36 kinetic
parameters (Table 1), compared to 84 parameters in the
full rate laws by Chassagnole et al. [17]. A WSLS param-
eter estimation was carried out for the simplified kinetic
model, and the optimal parameter and concentration
values were found. When the simplified rate laws were
used, the value of the WSLS objective function decreased
by half, most likely because it was easier to search the feas-
ible space of the simpler kinetic model and find a better
solution. The kinetic model simplification process signifi-
cantly improved the relative confidence intervals for kinetic
parameters compared to the full kinetic model (Figure 2).
Optimal values and confidence intervals for kinetic para-
meters can be found in Table 2.
Three types of parameters remained in the simplified
kinetic model: enzyme catalytic rate constants (kcat),
equilibrium constants (Keq), and binding coefficients
(Km). Equilibrium constants had the smallest relative con-
fidence intervals, as changes in these parameters caused
very large changes in the kinetic model enzyme and me-
tabolite concentrations. Binding coefficients generally had
small relative confidence intervals, as binding coefficients
that could not be estimated reliably were eliminated in
kinetic model simplification. Enzyme activities had the lar-
gest relative confidence intervals, and this was especially
true for some reversible reactions. For reversible reactions









vGAPD kcateGAPD cnadcgap  c13dpgcnadhKeq
 














vRPI kcateRPI cru5pD  cr5pKeq
 
vTALA kcateTALA cgapcs7p  ce4pcf6pKeq
 
Table 2 Estimated parameter values and confidence intervals
Parameter Value 95% Confidence Units
PTS kcat 20.7 ±9.1 mmol/mg protein/hr
PGI kcat 40.2 ±9.5 mmol/mg protein/hr
Keq 1.23 ±0.29 Dimensionless
PFK kcat 26 ±35 mmol/mg protein/mM/hr
ALDO kcat 3.965 ±0.010 mmol/mg protein/mM/hr
Keq 0.18 ±0.17 mM
Kfdp 0.0074 ±0.0036 mM
TPI kcat 10000 ±14000 mmol/mg protein/hr
Keq 0.11400 ±0.00031 Dimensionless
GAPD kcat 10000 ±4100 mmol/mg protein/mM
2/hr
Keq 1.21 ±0.14 Dimensionless
PGM kcat 9995 ±40 mmol/mg protein/hr
Keq 0.53570 ±0.00063 Dimensionless
PGK kcat 54.3 ±2.9 mmol/mg protein/hr
Keq 5512.1 ±1.2 Dimensionless
ENO kcat 2 ±45 mmol/mg protein/mM/hr
Keq 1.4 ±4.1 Dimensionless
PYK kcat 40 ±49 mmol/mg protein/hr
PDH Kcat 10.4 ±4.6 mmol/mg protein/hr
Kpyr 0.000020 ±0.000029 mM
4
PPC kcat 2.15 ±1.80 mmol/mg protein/hr
Kfdp 2.5 ±6.5 mM
Kpep 0.10 ±0.16 mM
G6PDH kcat 859.6 ±1.1 mmol/mg protein/mM
2/hr
GND kcat 18.5 ±10.8 mmol*mM/mg protein/hr
K6pg 0.021 ±0.012 mM
RPI kcat 549.46 ±0.69 mmol/mg protein/mM/hr
Keq 1.40000 ±0.00019 Dimensionless
RPE kcat 10000 ±13000 mmol/mg protein/mM/hr
Keq 0.4900 ±0.0044 Dimensionless
TKT1 kcat 10000 ±7800 mmol/mg protein/mM
2/hr
Keq 1.99 ±0.012 Dimensionless
TKT2 kcat 10000 ±5800 mmol/mg protein/mM
2/hr
Keq 3.500 ±0.013 Dimensionless
TALA kcat 10000 ±2300 mmol/mg protein/mM
2/hr
Keq 0.3675 ±0.0021 Dimensionless
Binding coefficient parameters have units of mM, except for Kpyr in PDH, which has units of mM
4. Equilibrium constants (Keq) are dimensionless, except for ALDO,
which has units of mM. Values for kcat have units such that fluxes have units of mmol/gDW/h. Global upper and lower bounds for binding and enzyme activity
were 104 and 10-6, respectively. Bounds on equilibrium constants were 0.35Keq
o and 2.85Keq
o , where Keq
o is the measured equilibrium constant.
Cotten and Reed BMC Bioinformatics 2013, 14:32 Page 6 of 13
http://www.biomedcentral.com/1471-2105/14/32catalytic rate constant is much larger than the reaction flux
since the mechanistic function, f, is close to zero. The en-
zyme catalytic rate constants cannot be determined for
these reactions with precision unless the reaction operates
further from equilibrium. Disregarding the reactions that
are often near equilibrium, the remaining enzyme activitieshave relative confidence intervals that are similar to bind-
ing and equilibrium constants.
Evaluation of optimal concentrations
Though parameters for these rate laws have been reported
previously in the literature, we found that kinetic parameter
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values. When binding coefficient values were fixed to
previously-reported in vitro or in vivo values (reported by
Chassagnole et al. [17]) in the full kinetic model, no feasible
solution could be found to Equations 1b-1e after several
thousand nonlinear programming runs from random start-
ing points where kcat values could vary. Biologically-
relevant bounds on the equilibrium constants (Keq) and me-
tabolite or protein concentrations (0.001 to 10 mM and
0.001 to 10 mg protein/gDCW, respectively) in part caused
this infeasibility. When bounds were not included in the
optimization problem, feasible solutions with large WSLS
could be found. In contrast, feasible solutions with small
WSLS were found after a few dozen starting points when
binding coefficients and kcat values were all allowed to


















































Figure 3 Model Estimates of All Metabolite and Protein Concentratio
and model estimates of (A-C) metabolite and (D) protein concentrations fo
glucose, g6p: glucose-6-phosphate, f6p: fructose-6-phosphate, fdp: fructose
1,3-diphosphoglycerate, pep: phosphoenolpyruvate, pyr: pyruvate, 6gpc: 6-
5-phosphate, nad: nicotinamide adenine dinuceotide (oxidized), nadh: nico
dinuceotide phosphate (oxidized), nadh: nicotinamide adenine dinuceotide
dehydrogenase, PykF: Pyruvate kinase, Gnd: 6-phosphogluconate dehydrog
Ppc: Phosphoenolpyruvate carboxylase, PtsH: Phosphotransferase system, H
Pgk: Phosphoglycerate kinase, Eno: Enolase, Pgl: 6-phosphogluconolactona
Transaldolase B, LpdA: Lipoamide dehydrogenase (part of pyruvate dehydrhave been previous results showing that in vitro kinetic
parameters are significantly different than their correspond-
ing in vivo values [25-27].
In addition to comparing kinetic parameters with
reported values, we also examined how well the simplified
kinetic model fit experimental concentration measu-
rements. Figure 3 shows a comparison between kinetic
model predicted concentrations (when the best set of kin-
etic parameters are used) and experimental observations
for metabolite and enzyme concentrations across all 20
conditions that were used to estimate kinetic parameters.
Though the predictions did deviate from reported values,
for most cases they fell within one standard deviation of
the measured values (Figure 4). Considering all 20 con-
ditions, 94.0% of the estimated enzyme concentrations































































n Measurements. Comparison between experimental measurements
r all 20 conditions in the training set. Abbreviations are as follows. glc:
-1,6-bisphosphate, dhap: dihydroxyacetone phosphate, 13dpg:
phosphogluconate, s7p: sedulose-7-phosphate, ru5pD: rubulose-
tinamide adenine dinuceotide (reduced), nadp: nicotinamide adenine
phosphate (reduced), GapA: Glyceraldehyde phosphate
enase, RpiA: Ribulose 5-phosphate isomerase A, TktB: Transketolase II,
subunit, PfkB: Phosphofructokinase II, Tpi: Triosephosphate isomerase,
se, Rpe: Ribulose 5-phosphate epimerase, TktA: Transketolase I, TalB:
ogenase complex).

































































Figure 4 Comparison Between Estimated and Measured
Concentrations with Experimental Errors. Comparison between
experimental measurements and model estimates of metabolite and
protein concentrations for a representative condition. Error bars
indicate one standard deviation for each measurement.
Abbreviations match those in Figure 3.
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ation of the measured values.
The kinetic model predicted ribose-5-phosphate (r5p)
and ribulose-5-phosphate (ru5p) concentrations deviated
more from experimental measurements (Figure 3B) as
compared to glycolytic and energy/redox carrier metabo-
lites. This was not surprising because the pentose phos-
phate pathway metabolites had larger experimental
variance, and thus were weighted less in WSLS parameterestimation. When all other measurements and kinetic rate
laws were excluded from the WSLS problem, the rate laws
for RPE and RPI were still difficult to fit to the r5p and ru5p
measurements (data not shown), indicating that the pro-
posed rate laws for these two reactions or their associated
protein/metabolite measurements may be problematic.
Kinetic and thermodynamic limitations in central
metabolism
Since the kinetic parameters included estimates of equi-
librium constants (Keq), it was possible to calculate the
Gibbs free energy change of reaction in cellular condi-
tions ΔGj = − RT ln(Keq,j) and further investigate thermo-
dynamic limitations in central metabolism. Taking the
estimates of metabolite concentrations from the best
WSLS parameter estimation result, the Gibbs free en-
ergy change of reaction in specific conditions was calcu-
lated as ΔGj ¼ ΔGj þ RT
X
i
Sij ln cið Þ (Figure 5A). In
many cases, ΔGj
* could not be calculated from the full
data set because various concentration measurements
were missing. We examined flux control from a thermo-
dynamic perspective because reactions close to equilib-
rium have lower control on fluxes through the rest of
metabolism [28]. It is often assumed that reactions that
are far from equilibrium are regulated by microbial cells
[7]. Examining the ΔG* values allows us to identify likely
metabolic engineering targets without explicitly calculat-
ing flux control coefficients.
Across all 20 considered conditions, the mean
ΔGALDO
* and ΔGENO
* were less than −10 kJ/mol, indicat-
ing that fructose-bisphosphate aldolase (ALDO) and eno-
lase (ENO) are often far from equilibrium and among the
best targets to control flux through central metabolism
[7]. The values for ΔGALDO
* could be calculated directly
from measurements as well, and these were also found to
be on the same order of magnitude and far from equilib-
rium. These results indicate that, although ALDO and
ENO are generally considered to be near equilibrium in
human erythrocytes [29], this may change depending on
the organism and environmental conditions. Other reac-
tions, including pyruvate dehydrogenase (PDH), pyruvate
kinase (PYK), phosphofructokinase (PFK), and glucose
transport (PTS), are known to be irreversible and thus do
not have a Keq in the kinetic model. These irreversible reac-
tions were observed to have large negative ΔGj
* values in all
experimental conditions when in vitromeasured ΔGj values
in standard conditions were used (data not shown) [21].
Most conditions had similar ΔGj
* values for a given reac-
tion, indicating that the same thermodynamic limitations
may arise regardless of the environmental or genetic
changes made to the organism. However, five reactions
(ribose phosphate isomerase, RPI; transketolase, TKT2;
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Figure 5 Thermodynamic Limitations and Metabolite Effects on Enzyme Activities. Metabolite names are in lowercase and reaction names
are in uppercase. (A) Histograms of ΔG* in kJ for each reaction across different conditions. Bin height indicates the number of conditions with
ΔG* between the two values on the x-axis. Values less than −10 kJ indicate a strong thermodynamic driving force for the reaction, and values
near 0 indicate proximity to equilibrium. Mean values and standard deviations for ΔG* for each reaction are also shown at the bottom right.
No histograms are shown for irreversible reactions. Abbreviations are as follows. PGI: phosphoglucose isomerase, GAPD: glyceraldehyde
phosphate dehydrogenase, ALDO: fructose bisphosphate aldolase, TPI: triosephosphate isomerase, PGK: phosphoglycerate kinase, PGM:
phosphoglucomutase, ENO: enolase, RPE: ribulose 5-phosphate epimerase, RPI: ribulose 5-phosphate isomerase, TKT1: transketolase I, TKT2:
transketolase 2, TALA: transaldolase (B) Apparent secondary effects of metabolite levels in the central metabolism. Inhibition effects are denoted
by lines with perpendicular ends. Activation effects are denoted by lines with arrow tips. Intermediate effects (concentration same order of
magnitude as binding coefficient) are in yellow. Stronger effects are in red (inhibition) or green (activation).
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ited different ΔGj
* values for a few conditions, indicating
that these five reactions may also control flux through
central metabolism under certain conditions. However,
the variation in estimated ΔGj
* values for the pentose
phosphate reactions (RPI and TKT2) could be due to
nosier (and/or missing) metabolite concentration mea-
surements and to larger differences between predicted and
measured concentrations for metabolites in this pathway
(Figure 3). ΔGj
* variations could also be due to errors in
estimated Keq values, since PGK and PGI both had large
Keq confidence intervals (the confidence intervals for theother three reaction’s Keq values were small). For the con-
ditions where the ΔGj
* values differed the most we did not
observe any consistent patterns in the data that would ex-
plain these shifts in ΔGj
* values, such as high or low me-
tabolite concentrations or high or low flux per enzyme
concentration values.
Although many binding coefficient parameters were
removed during kinetic model simplification, some binding
coefficients could be estimated with reasonable confidence
intervals. These binding coefficients could then be com-
pared to metabolite concentrations, to identify enzymes
whose activity appears to be substantially influenced by
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be useful for metabolic engineering applications, as they
show the enzyme-metabolite interactions that appear to be
biologically-relevant in a variety of growth conditions. For
example, inhibition of the glucose transport (PTS) by the
pyruvate/phosphoenolpyruvate (cpyr/cpep) ratio was pro-
posed in the rate laws by Chassagnole et al. [17] but this
inhibition was unimportant and was removed during kin-
etic model simplification, while the proposed activation of
phosphoenolpyruvate carboxylase (PPC) by fructose 1,6-
bisphosphate (Cfdp) was shown to substantially affect the
PPC flux. Because of these kinetic model simplifications,
the results clarify which inhibitory and activation effects
































































































Figure 6 Kinetic Flux Balance Analysis. Comparisons between FBA and
(A,B) or genome-scale constraint-based metabolic model (C,D). (A) Bar hei
using a central metabolic model. Residual was calculated as the squared d
height indicates the biomass yield from experiments or predictions from F
the iJO1366 model in KFBA for different numbers of kinetic flux bound vio
equivalent to the FBA solution. (D) Biomass yields when using the iJO1366
results when the minimum number of kinetic flux bound violations are alloPredictions using constraint-based model with kinetic
constraints
To evaluate the kinetic model on independent datasets
(i.e., those not used to estimate parameters), fluxes in five
test conditions were predicted using a constraint-based
model with (KFBA) and without (FBA) flux bounds calcu-
lated from the kinetic model (Additional file 3). Residuals
between experimental and predicted flux values from the
constraint-based model were calculated for each test con-
dition, reaction, and algorithm (Figure 6). In addition, bio-
mass yields were predicted using FBA and KFBA by
dividing the growth rate by the predicted glucose uptake
rate. These flux residuals and biomass yields allowed us to
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ifference between measurement and FBA or KFBA prediction. (B) Bar
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lations (n*). When all flux bounds are ignored the KFBA solution is
model. KFBA yield predictions (green) correspond to the yield that
wed.
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Overall, using KFBA the flux residuals for the five test
conditions were significantly smaller than the flux resi-
duals from FBA (p=0.0375 using sign test). In addition,
the KFBA predicted biomass yields were closer to experi-
mental values than FBA predicted biomass yields (p=0.063
using sign test). Together these results illustrate how kin-
etic constraints can be used to improve predictions for
intracellular fluxes and biomass yield, and demonstrate
the applicability of these constraints in conditions outside
of the training set.
For the Δzwf, Δpgm, ΔtktB, and D=0.5 h-1 conditions,
the mean residual from KFBA was smaller than the
mean residual from FBA (Figure 6A). Uptake and secre-
tion fluxes were also better predicted for these condi-
tions. The Δpgm mutant has a growth defect (biomass
yields are reduced by ~12% [16]), needing larger glucose
uptake and carbon dioxide secretion rates when com-
pared to the parental strain at the same growth rate.
However, FBA predicts the same biomass yields for the
Δpgm mutant as the parental strain at a growth rate of
0.2 h-1 and has 16.5% error and 27.7% error in the pre-
dicted glucose uptake and carbon dioxide production
rates, respectively. The KFBA algorithm correctly predicts
a lower Δpgm mutant biomass yield than the parental
strain (Figure 6B), with just a 1% error and 3.2% error in
the glucose uptake and carbon dioxide production rates,
respectively. In this KFBA solution, PDH, PPC, and TKT2
reactions are all at their lower kinetic bounds, and carbon
is forced through glycolysis and the pentose phosphate
pathway that is not ultimately incorporated into biomass,
and is instead secreted as carbon dioxide.
Not all predictions were improved by using the kinetic
constraints. The residuals for the intracellular fluxes pre-
dicted by KFBA for the ΔgpmA mutant were greater
than those predicted by FBA. In this case, the kinetic
bounds associated with the PTS and PDH reactions
caused KFBA to incorrectly predict fluxes through gly-
colysis, contributing to the large mean residual for
KFBA. Removing the PTS and PDH bounds reduced the
mean residual to 0.39, similar to FBA.
We also repeated the FBA and KFBA analysis using
the iJO1366 genome-scale constraint-based model. The
iJO1366 model contains more reactions in and around
central metabolism. As a result, we found that fewer kin-
etic constraints need to be violated, as compared to the
central model, and that pathways were predicted to be
used that are not normally operational under glucose
aerobic conditions (e.g., non-PTS glucose transport, glu-
cose dehydrogenase, gluconate kinase, isocitrate lyase
and xylose isomerase). We further evaluated how the
KFBA solutions changed as the number of allowable kin-
etic flux bound violations (n*) increased (Figure 6C).
These results show that there is a tradeoff betweenmaximizing agreement with the kinetic flux bounds and
not activating additional pathways (not included in the
central metabolic model), which causes poorer agree-
ment with experimental flux measurements. As observed
with the central metabolic model, the biomass yields
were predicted better when kinetic constraints were
imposed (Figure 6D). To improve KFBA predictions of
central metabolic fluxes, kinetic constraints for add-
itional pathways (noted above) in the iJO1366 model
need to be included.
Conclusions
Constraint-based modeling uses mass balances, flux cap-
acities, reaction directionalities, and other relevant physical
constraints to predict fluxes through metabolism. Although
transcriptional regulatory and thermodynamic constraints
have been integrated into this modeling approach, detailed
kinetic constraints have not been extensively formulated,
parameterized, and used in constraint-based models. Since
kinetic constraints are often omitted from constraint-
based models, some predicted flux distributions may not
be achievable using native enzymes or protein levels. In-
corporation of kinetic constraints into constraint-based
allows multi-omic datasets to be used to find kinetic lim-
itations on metabolic fluxes and suggests enzymes to tar-
get for improving cell behavior. For example, the Δpgm
mutant is predicted to have lower biomass yields due to
kinetic limitations, and the KFBA model suggests that
decreasing PDH, PPC, and TKT2 levels would improve
biomass yields for this mutant. One challenge with
developing such kinetically-constrained models is finding
kinetic parameter values that are consistent with experi-
mental measurements.
In this study, a WSLS parameter estimation problem
using multi-omic experimental data from a study by Ishii
et al. [16] was formulated and solved. The parameter es-
timation results suggested changes to functional forms
of rate laws, which were implemented to produce a sim-
plified kinetic model. The simpler kinetic model is an
improvement over the more detailed model because the
parameters are better-resolved and the model could be
solved more efficiently with a better fit to experimental
data. Each of the retained metabolite-enzyme binding
coefficient parameters were associated with measured
metabolite concentrations, and more binding parameters
could be retained in the future by measuring concentra-
tions for more chemical species. Overall, the kinetic
parameters we estimated could fit the kinetic model to
92.7% of the 720 measured metabolite and protein con-
centration measurements within one standard deviation
across 20 different experiments.
The thermodynamic predictions about distance from
equilibrium can also be used for metabolic engineering
applications [7]. In this case, reactions that are far from
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zyme levels, preventing them from reaching equilibrium.
Here, we identified reactions that were far from equilib-
rium during growth in most conditions, which represent
viable candidates for modifications to control flux
through metabolism. The results of thermodynamic ana-
lysis from this study are consistent with other thermo-
dynamic analysis of microbes. In a study by Kümmel
et al. [7], it was found that the ALDO reaction in E. coli
is not near equilibrium under physiological conditions.
Klimacek et al. [30] found that the ALDO and ENO
reactions are far from equilibrium in wild type and engi-
neered Saccharomyces cerevisiae strains. Our results
combined with these earlier studies indicate that E. coli
and S. cerevisiae must use significantly different strat-
egies for regulation of glycolysis than human erythro-
cytes, which instead closely regulate entry into and exit
from glycolysis, and have reactions near equilibrium for
all intermediate steps [29]. Enzymes were also identified
where metabolite concentrations had significant binding,
saturation, and allosteric regulatory effects. The conclu-
sions about thermodynamics and enzyme binding are
based on a simultaneous analysis of metabolomic, prote-
omic, and fluxomic data.
When kinetic constraints were imposed on a central
metabolic constraint-based model the flux and biomass
yield predictions were more accurately predicted by KFBA
than FBA. Imposition of kinetic constraints in a genome-
scale model provided mixed results, with more accurate
biomass yields but worse overall flux residuals after
incorporation of kinetic constraints. Since additional path-
ways are utilized in iJO1366 to match more kinetic flux
bounds, the application of more kinetic constraints could
improve predictions in more comprehensive models. The
confidence intervals for kinetic parameters allowed rea-
sonable flux ranges to be estimated from metabolite and
enzyme concentration data. For the five test conditions that
were evaluated, a median of 16 (out of 22) kinetic flux
bounds were feasible. We considered potential errors in
estimated parameter values to calculate the kinetic flux
bounds, but errors in metabolite and protein concentration
measurements could also be considered. The KFBA method
used in this work could be applied to other reported rate
laws, kinetic parameters, and concentration data, provided
reasonable flux ranges can be calculated. However, identify-
ing reasonable flux ranges may require parameter con-
fidence intervals, which are not always available.
The presented approach to parameterize kinetic rate
laws using in vivo data is general and can be applied to
multi-omics data from other microbes. We chose pub-
lished rate laws for a starting point for our kinetic
model, but we note that these rate laws are almost en-
tirely based on mass-action kinetics and Michaelis-
Menten type inhibition. These rate laws were sufficientfor our system, and we suggest the use of similar expres-
sions for pathways where rate laws have not been pro-
posed. The methods for imposing kinetic constraints in
constraint-based models are also general, and can be
used with rate laws with in vitro or in vivo determined
parameters. Methods to parameterize and use kinetic
rate laws in constraint-based models will benefit from
more global and precise metabolomics and proteomics
methods. Future work will involve including rate laws
for other metabolic pathways (such as the citric acid
cycle, fermentative and respiratory pathways) and esti-
mating their in vivo kinetic parameters. Overall, this
work illustrates how kinetic constraints can be used to
improve predictions for intracellular fluxes and biomass
yield and identify potential metabolic limitations through
the integrated analysis of multi-omics datasets.
Additional files
Additional file 1: Contains Table S1 – Rate laws used in the full and
simplified models. Rate laws in the full model (middle column) and
simplified model (right column). Each rate law in the simplified model
was deduced directly from the corresponding rate law and optimal
parameter values in the full model. Parameters shown in bold face are
those that had relative confidence intervals exceeding 100.
Additional file 2: Contains Table S2 - Estimated parameter values
and confidence intervals. Binding coefficient parameters have units of
mM, except for Kpyr in PDH, which has units of mM
4. Equilibrium
constants (Keq) are dimensionless, except for ALDO, which has units of
mM. Values for kcat have units such that fluxes have units of mmol/gDW/
h. Units for kcat may differ between full and simplified models.
Additional file 3: Contains the Kinetic Model in SBML format.
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